These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3932166)

  • 1. Utility of monoclonal antibodies to define different stages of maturation of B cells in Waldenström's macroglobulinemia.
    Volpe S; Cantore N; Fotino A; Pagnini D; Volpe E
    Haematologica; 1985; 70(3):274. PubMed ID: 3932166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Waldenström's macroglobulinemia].
    Arderiu Freixa A; Ordi Ros J; Mirada Canals A
    Rev Clin Esp; 1981 Nov; 163(3):151-6. PubMed ID: 6799992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Waldenström's macroglobulinemia].
    Brouet JC
    Rev Prat; 1979 Jan; 29(3):317-20, 323-4, 329. PubMed ID: 105399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Waldenström's macroglobulinemia with systemic lupus erythematosus. A case report (author's transl)].
    Marchesi E
    Haematologica; 1978 Apr; 63(2):209-15. PubMed ID: 98402
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of antibody specificity of the monoclonal component in a case of Waldenström's macroglobulinemia].
    Giovanna Zaninetta M; Moccia F; Paolo Mazzarello G; Mansuino P; Morra L
    Ann Ital Med Int; 1992; 7(1):42-5. PubMed ID: 1524946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies on the origin of the precursor cells in Waldenström's macroglobulinemia.
    Ricci C; Bozzone DM; Cascio G; Marchi L; Baldassi R; Formosa A
    Cancer Detect Prev; 1985; 8(1-2):261-70. PubMed ID: 3933833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Waldenström's macroglobulinemia with IgG monoclonal component].
    Morey M; Bargay J; Durán MA; Matamoros N
    Med Clin (Barc); 1992 Mar; 98(11):436-7. PubMed ID: 1569796
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications.
    Mellstedt H; Holm G; Björkholm M
    Adv Cancer Res; 1984; 41():257-89. PubMed ID: 6428176
    [No Abstract]   [Full Text] [Related]  

  • 10. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal immunoglobulins].
    Brouet JC
    Ann Med Interne (Paris); 1996; 147(8):567-9. PubMed ID: 9137683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of Waldenström's macroglobulinemia with cold agglutinin disease].
    Suzuki M; Noda T; Kodama H; Sahashi K; Wakita A
    Rinsho Ketsueki; 1986 Mar; 27(3):376-80. PubMed ID: 3090303
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Waldenström's macroglobulinemia with an uncommon presentation].
    Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
    Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disease observations in hematologic system diseases (leukemia Waldenström's disease) and immunologic deficiencies using B- and T-cell specific markers].
    Beyer JH; Hertenstein C; Lipke M; Schmidt CG; Wetter O
    Verh Dtsch Ges Inn Med; 1974; 80():1502-5. PubMed ID: 4217983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemical, physico-chemical and immunochemical aspects of Waldenström's macroglobulinemia].
    Mesnier F
    J Med Bord; 1967 Sep; 144(9):1249-66. PubMed ID: 4194653
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waldenström's macroglobulinemia and myasthenia gravis.
    Bartoloni C; Scoppetta C; Flamini G; Guidi L; Bartoccioni E; Lambiase M; Gambassi G; Terranova T
    J Clin Lab Immunol; 1981 Nov; 6(3):275-8. PubMed ID: 6802976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative disorders of the plasma cell.
    Boulter MJ
    Am Fam Physician; 1982 Oct; 26(4):169-77. PubMed ID: 6812402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens.
    Dimopoulos MA; Kastritis E; Delimpassi S; Zomas A; Kyrtsonis MC; Zervas K
    Haematologica; 2008 Sep; 93(9):1420-2. PubMed ID: 18641029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.